TE-8105 is a GLP-1 receptor agonist that demonstrates prolonged and enhanced efficacy in models of diabetes, obesity, and non-alcoholic steatohepatitis (NASH).
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
